Biomedical Advanced Research and Development Authority logo
Funder · Federal agency

Biomedical Advanced Research and Development Authority

Funds BARDA, the Department of Health and Human Services directorate supporting countermeasures for public health emergencies.

United Statesmedicalcountermeasures.gov
Key stats
Annual funding$1.7B
Programs10
Active grants7
Total grants9
About

Biomedical Advanced Research and Development Authority (BARDA) sits within HHS's Administration for Strategic Preparedness and Response and funds medical countermeasures for chemical, biological, radiological, and nuclear threats, pandemic influenza, and emerging infectious diseases. It was built under Project BioShield in 2004 and now operates at a reported annual spending level of about $1.7 bil…

Programs & grants under this funder
BARDA Accelerator Network (BAN)

Funds proof-of-concept teams in the BARDA ecosystem with early-stage non-dilutive support for medical solutions.

1 grant
BARDA Accelerator Network — POC Funding
Open
— pool·Rolling submission
BARDA Broad Agency Announcement (BAA)

Funds advanced medical countermeasure development in the United States across multiple national threat focus areas.

1 grant
BARDA BAA (through
Open
— pool·764 days
BARDA DRIVe

Offers early health-security startup support through a fast track mechanism and innovation hubs for proof of concept.

3 grants
BARDA Accelerator Network — Proof-of-Concept Funding
Open
$15M pool·Rolling submission
DRIVe EZ-BAA Plus Phase (Advanced Development)
Closed
$80M pool
DRIVe EZ-BAA Standard
Closed
$25M pool
BARDA DRIVe Easy BAA (EZ-BAA)

Funds United States health security teams through BARDA DRIVe support for rapid response innovation.

BARDA DRIVe ImmuneChip+

Funds advanced immune and biological testing platforms for medical countermeasure development through challenge-style calls.

1 grant
BARDA DRIVe ImmuneChip+ (through
Open
— pool·767 days
BARDA DRIVe ReDIRECT (Repurposing for Chem Threats)

Funds United States public health teams with BARDA DRIVe support for repurposing-focused solutions.

Project BioShield

Funds development and procurement readiness of medical countermeasures for chemical, biological, radiological, and nuclear threats.

1 grant
Project BioShield Procurement
Open
$800M pool·Rolling submission
BARDA Rapid Response Partnership Vehicle (RRPV)

Provides rapid-response vaccine and medicine development collaboration across many partners for urgent national threats.

1 grant
BARDA RRPV — Member
Open
— pool
BARDA DRIVe Solving Sepsis Initiative

Funds United States healthcare teams with BARDA DRIVe support for sepsis-focused innovation.

BARDA Ventures

Invests in transformative countermeasure companies in the United States through growth-stage partnerships with public partners.

1 grant
BARDA Ventures — Equity Co-Investment
Open
— pool·Rolling submission
Parent entityUS Department of Health and Human Services
Last verified: 27 May 2026Source: medicalcountermeasures.gov